#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dent's disease Brain abscess Pancreatic neuroendocrine tumour Epileptic encephalopathy Hepatic cirrhosis Hypomagnesaemia Familial amyotrophic lateral sclerosis Antithrombin III deficiency Porphyria non-acute Adrenoleukodystrophy Exudative retinopathy Insulinoma Haemophilia A without inhibitors Marginal zone lymphoma refractory Ewing's sarcoma More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Life with Disease Medulloblastoma recurrent – Trials in Disease Haemophilia – Diagnostics Medulloblastoma recurrent – Life with Disease Leiomyosarcoma Mitochondrial myopathy Synovial sarcoma metastatic – Basic Information Medulloblastoma recurrent – Diagnostics Fabry’s disease – Life with Disease Mantle cell lymphoma stage II More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Exidavnemab Ponatinib Imlifidase Albiglutide Sotagliflozin IDP-121 Levoleucovorin Cefazolin Sodium Tozinameran NORGESTIMATE Dronedarone IBANDRONIC ACID Deferoxamine Allo-501A Piflufolastat (18F) Interleukin-2 Erythromycin Hct116-A Heterodimeric Interleukin-15 Ambrisentan More therapies…

    Learn about Your Condition

    Synovial sarcoma recurrent Lymphocytic lymphoma Herpes simplex meningitis Head and neck cancer stage III Tendon injury Peyronie's disease Liver disorder Aneurysm ruptured Penile cancer Chondrosarcoma Myeloproliferative neoplasm Cardiac sarcoidosis Lichen planopilaris Acute lymphocytic leukaemia Intervertebral disc protrusion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pathological Conditions, Signs and Symptoms

  • Methoxyflurane versus oral oxycodone hydrochloride and morphine sulfate for pain relief in sickle cell disease vaso‑occlusive crises

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Morphine Sulfate
    • Oxycodone Hydrochloride
    France

  • A study to evaluate the use of meropenem to reduce the risk of sepsis in patients with suspected infection in the emergency department

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bacterial infection
    • Sepsis
    Investigated Drugs:
    • Meropenem Anhydrous
    • Sodium Chloride
    Greece

  • A study to evaluate the effectiveness of ispaghula husk in patients with low anterior resection syndrome after rectal cancer surgery

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Low anterior resection syndrome
    Investigated Drugs:
    • ISPAGHULA HUSK
    Norway

  • Comparing the timing of etoposide and dexamethasone treatment for patients with severe sporadic hemophagocytic lymphohistiocytosis in intensive care.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Dexamethasone Acetate
    • Etoposide
    France

  • Comparing morphine and alfentanil for treating severe acute pain in adults before hospital admission

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • ALFENTANIL HYDROCHLORIDE
    • Morphine Hydrochloride
    France

  • Study comparing oral and injectable nefopam in patients with acute rheumatologic pain to evaluate how the medication is processed by the body

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pain
    Investigated Drugs:
    • Nefopam Hydrochloride
    France
Previous Page
1 … 11 12 13 14 15 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!